aluates Reports

$ 0.0

Automative

Global Helminthic Infestations Therapeutics Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-25A13782

Global Helminthic Infestations Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Helminthic Infestations Therapeutics Market Research Report 2024

Code: QYRE-Auto-25A13782

Report

August 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Neural Analytics, Inc.

M3 Biotechnology, Inc.

Cerevance

Mitochon Pharmaceuticals, Inc.

Peptilogics

Farmoquimica S/A

BiOasis Technologies Inc

HCA Healthcare, Inc.

Alzeca Biosciences, Inc.

Johnson & Johnson

Helminthic Infestations Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Helminthic Infestations Therapeutics Market

The global Helminthic Infestations Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Helminthic Infestations Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Helminthic Infestations Therapeutics.

Report Scope

The Helminthic Infestations Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Helminthic Infestations Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Helminthic Infestations Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Helminthic Infestations Therapeutics Market Report

Report Metric	Details
Report Name	Helminthic Infestations Therapeutics Market
CAGR	5%
Segment by Type	Benzimidazole Pyrantel Piperazine Citrate Others
Segment by Application	Enterobius vermicularis Taenia saginata Ascaris lumbricoides Trichuris trichiura Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Neural Analytics, Inc., M3 Biotechnology, Inc., Cerevance, Mitochon Pharmaceuticals, Inc., Peptilogics, Farmoquimica S/A, biOasis Technologies, Inc., HCA Healthcare, Inc., Alzeca Biosciences, Inc., Johnson & Johnson
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Helminthic Infestations Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Helminthic Infestations Therapeutics Market report?

Ans: The main players in the Helminthic Infestations Therapeutics Market are Neural Analytics, Inc., M3 Biotechnology, Inc., Cerevance, Mitochon Pharmaceuticals, Inc., Peptilogics, Farmoquimica S/A, biOasis Technologies, Inc., HCA Healthcare, Inc., Alzeca Biosciences, Inc., Johnson & Johnson

What are the Application segmentation covered in the Helminthic Infestations Therapeutics Market report?

Ans: The Applications covered in the Helminthic Infestations Therapeutics Market report are Enterobius vermicularis, Taenia saginata, Ascaris lumbricoides, Trichuris trichiura, Others

What are the Type segmentation covered in the Helminthic Infestations Therapeutics Market report?

Ans: The Types covered in the Helminthic Infestations Therapeutics Market report are Benzimidazole, Pyrantel, Piperazine Citrate, Others

Recommended Reports

Parasitic Therapeutics

Infectious Disease Drugs

Livestock and Agricultural

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Benzimidazole

1.2.3 Pyrantel

1.2.4 Piperazine Citrate

1.2.5 Others

1.3 Market by Application

1.3.1 Global Helminthic Infestations Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Enterobius vermicularis

1.3.3 Taenia saginata

1.3.4 Ascaris lumbricoides

1.3.5 Trichuris trichiura

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Helminthic Infestations Therapeutics Market Perspective (2019-2030)

2.2 Helminthic Infestations Therapeutics Growth Trends by Region

2.2.1 Global Helminthic Infestations Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Helminthic Infestations Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Helminthic Infestations Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Helminthic Infestations Therapeutics Market Dynamics

2.3.1 Helminthic Infestations Therapeutics Industry Trends

2.3.2 Helminthic Infestations Therapeutics Market Drivers

2.3.3 Helminthic Infestations Therapeutics Market Challenges

2.3.4 Helminthic Infestations Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Helminthic Infestations Therapeutics Players by Revenue

3.1.1 Global Top Helminthic Infestations Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Helminthic Infestations Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Helminthic Infestations Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Helminthic Infestations Therapeutics Revenue

3.4 Global Helminthic Infestations Therapeutics Market Concentration Ratio

3.4.1 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Helminthic Infestations Therapeutics Revenue in 2023

3.5 Helminthic Infestations Therapeutics Key Players Head office and Area Served

3.6 Key Players Helminthic Infestations Therapeutics Product Solution and Service

3.7 Date of Enter into Helminthic Infestations Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Helminthic Infestations Therapeutics Breakdown Data by Type

4.1 Global Helminthic Infestations Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2025-2030)

5 Helminthic Infestations Therapeutics Breakdown Data by Application

5.1 Global Helminthic Infestations Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Helminthic Infestations Therapeutics Market Size (2019-2030)

6.2 North America Helminthic Infestations Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Helminthic Infestations Therapeutics Market Size by Country (2019-2024)

6.4 North America Helminthic Infestations Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Helminthic Infestations Therapeutics Market Size (2019-2030)

7.2 Europe Helminthic Infestations Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Helminthic Infestations Therapeutics Market Size by Country (2019-2024)

7.4 Europe Helminthic Infestations Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Helminthic Infestations Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Helminthic Infestations Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Helminthic Infestations Therapeutics Market Size (2019-2030)

9.2 Latin America Helminthic Infestations Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Helminthic Infestations Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Helminthic Infestations Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Helminthic Infestations Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Helminthic Infestations Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Neural Analytics, Inc.

11.1.1 Neural Analytics, Inc. Company Detail

11.1.2 Neural Analytics, Inc. Business Overview

11.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Introduction

11.1.4 Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.1.5 Neural Analytics, Inc. Recent Development

11.2 M3 Biotechnology, Inc.

11.2.1 M3 Biotechnology, Inc. Company Detail

11.2.2 M3 Biotechnology, Inc. Business Overview

11.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Introduction

11.2.4 M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.2.5 M3 Biotechnology, Inc. Recent Development

11.3 Cerevance

11.3.1 Cerevance Company Detail

11.3.2 Cerevance Business Overview

11.3.3 Cerevance Helminthic Infestations Therapeutics Introduction

11.3.4 Cerevance Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.3.5 Cerevance Recent Development

11.4 Mitochon Pharmaceuticals, Inc.

11.4.1 Mitochon Pharmaceuticals, Inc. Company Detail

11.4.2 Mitochon Pharmaceuticals, Inc. Business Overview

11.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Introduction

11.4.4 Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.4.5 Mitochon Pharmaceuticals, Inc. Recent Development

11.5 Peptilogics

11.5.1 Peptilogics Company Detail

11.5.2 Peptilogics Business Overview

11.5.3 Peptilogics Helminthic Infestations Therapeutics Introduction

11.5.4 Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.5.5 Peptilogics Recent Development

11.6 Farmoquimica S/A

11.6.1 Farmoquimica S/A Company Detail

11.6.2 Farmoquimica S/A Business Overview

11.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Introduction

11.6.4 Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.6.5 Farmoquimica S/A Recent Development

11.7 biOasis Technologies, Inc.

11.7.1 biOasis Technologies, Inc. Company Detail

11.7.2 biOasis Technologies, Inc. Business Overview

11.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Introduction

11.7.4 biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.7.5 biOasis Technologies, Inc. Recent Development

11.8 HCA Healthcare, Inc.

11.8.1 HCA Healthcare, Inc. Company Detail

11.8.2 HCA Healthcare, Inc. Business Overview

11.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Introduction

11.8.4 HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.8.5 HCA Healthcare, Inc. Recent Development

11.9 Alzeca Biosciences, Inc.

11.9.1 Alzeca Biosciences, Inc. Company Detail

11.9.2 Alzeca Biosciences, Inc. Business Overview

11.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Introduction

11.9.4 Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.9.5 Alzeca Biosciences, Inc. Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Detail

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Introduction

11.10.4 Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2019-2024)

11.10.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Neural Analytics, Inc.

M3 Biotechnology, Inc.

Cerevance

Mitochon Pharmaceuticals, Inc.

Peptilogics

Farmoquimica S/A

BiOasis Technologies Inc

HCA Healthcare, Inc.

Alzeca Biosciences, Inc.

Johnson & Johnson

List of Tables

Table 1. Global Helminthic Infestations Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Benzimidazole

Table 3. Key Players of Pyrantel

Table 4. Key Players of Piperazine Citrate

Table 5. Key Players of Others

Table 6. Global Helminthic Infestations Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Helminthic Infestations Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Helminthic Infestations Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Helminthic Infestations Therapeutics Market Share by Region (2019-2024)

Table 10. Global Helminthic Infestations Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Helminthic Infestations Therapeutics Market Share by Region (2025-2030)

Table 12. Helminthic Infestations Therapeutics Market Trends

Table 13. Helminthic Infestations Therapeutics Market Drivers

Table 14. Helminthic Infestations Therapeutics Market Challenges

Table 15. Helminthic Infestations Therapeutics Market Restraints

Table 16. Global Helminthic Infestations Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Helminthic Infestations Therapeutics Market Share by Players (2019-2024)

Table 18. Global Top Helminthic Infestations Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helminthic Infestations Therapeutics as of 2023)

Table 19. Ranking of Global Top Helminthic Infestations Therapeutics Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Helminthic Infestations Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Helminthic Infestations Therapeutics Product Solution and Service

Table 23. Date of Enter into Helminthic Infestations Therapeutics Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Helminthic Infestations Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Helminthic Infestations Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Helminthic Infestations Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Helminthic Infestations Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2019-2024)

Table 31. Global Helminthic Infestations Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Helminthic Infestations Therapeutics Revenue Market Share by Application (2025-2030)

Table 33. North America Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Helminthic Infestations Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Helminthic Infestations Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Helminthic Infestations Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Helminthic Infestations Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Helminthic Infestations Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Helminthic Infestations Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Helminthic Infestations Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Helminthic Infestations Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Helminthic Infestations Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Helminthic Infestations Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 48. Neural Analytics, Inc. Company Detail

Table 49. Neural Analytics, Inc. Business Overview

Table 50. Neural Analytics, Inc. Helminthic Infestations Therapeutics Product

Table 51. Neural Analytics, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 52. Neural Analytics, Inc. Recent Development

Table 53. M3 Biotechnology, Inc. Company Detail

Table 54. M3 Biotechnology, Inc. Business Overview

Table 55. M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Product

Table 56. M3 Biotechnology, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 57. M3 Biotechnology, Inc. Recent Development

Table 58. Cerevance Company Detail

Table 59. Cerevance Business Overview

Table 60. Cerevance Helminthic Infestations Therapeutics Product

Table 61. Cerevance Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 62. Cerevance Recent Development

Table 63. Mitochon Pharmaceuticals, Inc. Company Detail

Table 64. Mitochon Pharmaceuticals, Inc. Business Overview

Table 65. Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Product

Table 66. Mitochon Pharmaceuticals, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 67. Mitochon Pharmaceuticals, Inc. Recent Development

Table 68. Peptilogics Company Detail

Table 69. Peptilogics Business Overview

Table 70. Peptilogics Helminthic Infestations Therapeutics Product

Table 71. Peptilogics Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 72. Peptilogics Recent Development

Table 73. Farmoquimica S/A Company Detail

Table 74. Farmoquimica S/A Business Overview

Table 75. Farmoquimica S/A Helminthic Infestations Therapeutics Product

Table 76. Farmoquimica S/A Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 77. Farmoquimica S/A Recent Development

Table 78. biOasis Technologies, Inc. Company Detail

Table 79. biOasis Technologies, Inc. Business Overview

Table 80. biOasis Technologies, Inc. Helminthic Infestations Therapeutics Product

Table 81. biOasis Technologies, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 82. biOasis Technologies, Inc. Recent Development

Table 83. HCA Healthcare, Inc. Company Detail

Table 84. HCA Healthcare, Inc. Business Overview

Table 85. HCA Healthcare, Inc. Helminthic Infestations Therapeutics Product

Table 86. HCA Healthcare, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 87. HCA Healthcare, Inc. Recent Development

Table 88. Alzeca Biosciences, Inc. Company Detail

Table 89. Alzeca Biosciences, Inc. Business Overview

Table 90. Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Product

Table 91. Alzeca Biosciences, Inc. Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 92. Alzeca Biosciences, Inc. Recent Development

Table 93. Johnson & Johnson Company Detail

Table 94. Johnson & Johnson Business Overview

Table 95. Johnson & Johnson Helminthic Infestations Therapeutics Product

Table 96. Johnson & Johnson Revenue in Helminthic Infestations Therapeutics Business (2019-2024) & (US$ Million)

Table 97. Johnson & Johnson Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Helminthic Infestations Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Helminthic Infestations Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Benzimidazole Features

Figure 4. Pyrantel Features

Figure 5. Piperazine Citrate Features

Figure 6. Others Features

Figure 7. Global Helminthic Infestations Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Helminthic Infestations Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Enterobius vermicularis Case Studies

Figure 10. Taenia saginata Case Studies

Figure 11. Ascaris lumbricoides Case Studies

Figure 12. Trichuris trichiura Case Studies

Figure 13. Others Case Studies

Figure 14. Helminthic Infestations Therapeutics Report Years Considered

Figure 15. Global Helminthic Infestations Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Helminthic Infestations Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Helminthic Infestations Therapeutics Market Share by Region: 2023 VS 2030

Figure 18. Global Helminthic Infestations Therapeutics Market Share by Players in 2023

Figure 19. Global Top Helminthic Infestations Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Helminthic Infestations Therapeutics as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Helminthic Infestations Therapeutics Revenue in 2023

Figure 21. North America Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Helminthic Infestations Therapeutics Market Share by Country (2019-2030)

Figure 23. United States Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Helminthic Infestations Therapeutics Market Share by Country (2019-2030)

Figure 27. Germany Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Helminthic Infestations Therapeutics Market Share by Region (2019-2030)

Figure 35. China Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Helminthic Infestations Therapeutics Market Share by Country (2019-2030)

Figure 43. Mexico Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Helminthic Infestations Therapeutics Market Share by Country (2019-2030)

Figure 47. Turkey Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Helminthic Infestations Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Neural Analytics, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 50. M3 Biotechnology, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 51. Cerevance Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 52. Mitochon Pharmaceuticals, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 53. Peptilogics Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 54. Farmoquimica S/A Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 55. biOasis Technologies, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 56. HCA Healthcare, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 57. Alzeca Biosciences, Inc. Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 58. Johnson & Johnson Revenue Growth Rate in Helminthic Infestations Therapeutics Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Dewormer for Cats Market Research Report 2025

Antiparasitic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Heartworm Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Filariasis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Feed Anticoccidials Market Insights Forecast to 2030

Pediculosis and Pthiriasis Lice Infestation Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Infectives Market Research Report 2025

Global Lice Treatment Market Research Report 2024

Global Poultry and Livestock Anti Infective Drugs Market Research Report 2025

Global Osteomyelitis Treatment Market Research Report 2025

Global Inhaled Anti Infectives Market Research Report 2025

Global Ophthalmic Anti Infective Drugs Market Research Report 2025

Babesiosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Onchocerciasis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poultry Disease Diagnostic Kit Market Research Report 2025

Global Onychomycosis Treatment Technique Market Research Report 2024

Global Ant Killer Market Research Report 2024

Global Onychomycosis Therapy Market Research Report 2024

Pharmaceutical Grade Albendazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions